Hysterectomy, the surgical removal of the uterus, is one of the most common gynecological procedures worldwide. Robotic-assisted surgery has emerged as an advanced minimally invasive approach, offering significant advantages over traditional methods.
Advantages of Robotic Hysterectomy
Enhanced precision and flexibility: Robotic technology provides surgeons with high-definition 3D visualization and instruments with a wide range of motion, allowing for greater precision in movements.
Reduced postoperative pain and faster recovery: The small incisions and minimal invasiveness lead to less pain and quicker return to daily activities.
Lower risk of complications: Robotic surgery is associated with lower rates of bleeding and infections compared to open surgery.
Indications for Robotic Hysterectomy
Robotic hysterectomy is particularly indicated in the following cases:
Benign conditions: Fibroids, endometriosis, adenomyosis, and refractory uterine bleeding.
Endometrial cancer: The robotic approach is especially beneficial in patients with obesity (BMI ≥35), offering reduced risk of complications and lower conversion rates to open surgery .
Staging in ovarian cancer: Robotic surgery can be utilized for staging in selected cases of early-stage ovarian cancer, providing precision and minimal invasiveness .
Cervical cancer: The efficacy of robotic surgery in early-stage cervical cancer is currently being evaluated through the RACC trial and is not yet established as a standard method .
Guidelines and Recent Studies
According to ESGO guidelines:
Robotic hysterectomy is safe and effective for the treatment of endometrial cancer, particularly in patients with obesity .
The use of robotic surgery for staging in early-stage ovarian cancer is acceptable in selected cases, emphasizing surgeon experience and appropriate patient selection .
The efficacy of robotic surgery in early-stage cervical cancer is currently being evaluated through the RACC trial and is not yet established as a standard method .
References:
ESGO Guidelines: https://www.esgo.org/explore/guidelines/
RACC Trial: https://racctrial.org/
MDPI Study on Robotic Surgery in Obese Patients: https://www.mdpi.com/2072-6694/17/3/482
ESGO Guidelines on Ovarian Cancer Surgery: https://guidelines.esgo.org/media/2017/03/ESGO_ovarian_cancer_surgery_brA5_V01-website.pdf